Finerenone: First Approval
This article summarizes the milestones in the development of finerenone leading to this first approval to reduce the risk of serious kidney and heart complications in adults with CKD and T2D.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cardiology | Cardiovascular | China Health | Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Heart Attack | Heart Failure | Urology & Nephrology